According to a new study published in the Journal of Affective Disorders Reports, those with anxiety and/or PTSD who use medical marijuana experience symptom improvements and many reduce their intake of prescription anti-anxiety medications.
Titled Anxiety severity and prescription medication utilization in first-time medical marijuana users, the study was conducted by researchers at the Philadelphia College of Osteopathic Medicine and the Public Health Management Corporation.
“Anxiety and post-traumatic stress disorder (PTSD) are qualifying psychiatric conditions for medical marijuana (MM) treatment in Pennsylvania”, states the study’s abstract. “This study examined baseline prevalence and changes in prescription anxiety medication use three months following MM treatment initiation among individuals with these qualifying conditions.”
Continue reading